Pfizer (PFE) Accumulated Expenses (2009 - 2026)
Pfizer (PFE) posted quarterly Accumulated Expenses of $2.7 billion for Q1 2026, up 4.14% year-over-year from $2.6 billion in Q1 2025, and down 24.79% quarter-over-quarter from $3.6 billion in Q4 2025.
Pfizer (PFE) Accumulated Expenses (2009 - 2026) Analysis & Trends
Pfizer (PFE) has reported Accumulated Expenses for 18 consecutive years, with $2.7 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Accumulated Expenses rose 4.14% year-over-year to $2.7 billion; the TTM figure through Mar 2026 stood at $2.7 billion (up 4.14% YoY), while the FY2025 annual figure was $3.6 billion, down 5.94% from the prior year.
- Accumulated Expenses retreated to $2.7 billion in Q1 2026 per PFE's latest filing, from $3.6 billion in the prior quarter.
- Across five years, Accumulated Expenses topped out at $3.8 billion in Q4 2024 and bottomed at $2.0 billion in Q3 2023.
- Historically, Accumulated Expenses has averaged $2.7 billion across 5 years, with a median of $2.6 billion in 2025.
- Annual changes were most pronounced in 2023 — Accumulated Expenses retreated 18.52% — and 2024, when it soared 38.26%.
- Pfizer's Accumulated Expenses stood at $3.4 billion in 2022, then dropped by 18.52% to $2.8 billion in 2023, then soared by 38.26% to $3.8 billion in 2024, then fell by 5.94% to $3.6 billion in 2025, then fell by 24.79% to $2.7 billion in 2026.
- Business Quant data shows PFE's Accumulated Expenses at $2.7 billion in Q1 2026, $3.6 billion in Q4 2025, and $3.0 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 2.55 Bn |
| Mar 29, 2026 | 2.72 Bn |
| Dec 31, 2025 | 3.61 Bn |
| Sep 28, 2025 | 3.04 Bn |
| Jun 29, 2025 | 2.45 Bn |
| Mar 30, 2025 | 2.61 Bn |
| Dec 31, 2024 | 3.84 Bn |
| Sep 29, 2024 | 3.38 Bn |
| Jun 30, 2024 | 2.57 Bn |
| Mar 31, 2024 | 2.19 Bn |
| Dec 31, 2023 | 2.78 Bn |
| Jul 2, 2023 | 1.97 Bn |
| Apr 2, 2023 | 2.28 Bn |
| Dec 31, 2022 | 3.41 Bn |
| Jul 3, 2022 | 2.00 Bn |
| Apr 3, 2022 | 2.25 Bn |
| Dec 31, 2021 | 3.33 Bn |
| Oct 3, 2021 | 2.57 Bn |
| Jul 4, 2021 | 2.02 Bn |
| Apr 4, 2021 | 1.99 Bn |